Security key
74638P307
PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (PPBT)
CUSIP: 74638P307
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Ordinary Shares, no par value per share
- Total 13F shares
- 84,297
- Total 13F value
- $141,023
- Share change
- +10,598
- SEC-reported price per share
- $1.68
- Number of holders
- 12
- Value change
- +$15,459
- Number of buys
- 8
- Number of sells
- 9
- Shares outstanding
- 1,895,142,857
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
12
Top holders
10
PPBT full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
PURPLE BIOTECH LTD. SEC filings
PURPLE BIOTECH LTD. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74638P307
Recent filing periods:
Ownership snapshot
Top reported holders of PPBT - PURPLE BIOTECH LTD. - Ordinary Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
INTRACOASTAL CAPITAL, LLC
Disclosed value leader
INTRACOASTAL CAPITAL, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 10%
13D/G row: INTRACOASTAL CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
INTRACOASTAL CAPITAL, LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens INTRACOASTAL CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
INTRACOASTAL CAPITAL, LLC
10%
Lincoln Alternative Strategies LLC
9.9%
Orca Capital AG
4.9%
SUSQUEHANNA SECURITIES, LLC
1.4%
Gil Efron
0.56%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
10%
|
$124,305,955
282,513,535 shares
|
+$36,106,330 | 31 Mar 2026 |
| Lincoln Alternative Strategies LLC |
13D/G
|
9.9%
|
$1,288,650
605,000 shares
|
$0 | 04 Sep 2025 |
| Orca Capital AG |
13D/G
|
4.9%
|
$652,619
306,394 shares
|
$0 | 04 Sep 2025 |
| SUSQUEHANNA SECURITIES, LLC |
13D/G
G1 Execution Services, LLC
|
1.4%
|
$45,104,400
26,532,000 shares
|
$0 | 30 Jun 2026 |
| Gil Efron |
3/4/5
Chief Executive Officer
|
0.56%
|
$10,355,625
15,750,000 shares
|
— | 18 Mar 2026 |
| Michael Schickler |
3/4/5
Head of Clinical & Reg Affairs
|
0.33%
|
$6,084,815
9,254,472 shares
|
— | 18 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
12
Shares
84,297
Rows available
12
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
14
Q2 2026 holders
12
Holder diff
-2
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend